CNSP 8-K 2026-10-02
CNS Pharmaceuticals, Inc. (CNSP) 8-K dated 2026-10-02 — accession 0001683168-26-007552.
CNS Pharmaceuticals, Inc. (CNSP) is a biotechnology company listed on NASDAQ.
CNS Pharmaceuticals, Inc. filed a 8-K on 2026-10-02. Accession 0001683168-26-007552.
This 8-K covers: Director/officer change (Item 5.02), Shareholder vote results (Item 5.07), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported CNSP revenue for 2023-12-31 was $27.7K. Net income was -$18.9M. CNSP currently screens at market cap $6.6M.
Not investment advice. The CNSP SEC hub lists recent forms. The stock page is the research view.